| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 8, Issue 2 221-230, Copyright © 1997 by American Association of Cancer Research
ARTICLES |
SC Kiley, PD Adams and PJ Parker
Protein Phosphorylation Laboratory, Imperial Cancer Research Fund, London, United Kingdom.
Differentiation-resistant U937 cells were derived from parental U937 human promonocytic leukemia cells by selecting for a nonadherent phenotype in cell cultures continuously exposed to 12-O-tetradecanoylphorbol-13-acetate (TPA). Subsequent analysis indicated no differences between wildtype (wt) and resistant U937 cells with respect to protein kinase C (PKC) isozyme expression, activation, or down-modulation. The subcellular localization of PKCs is identical in wt and resistant cells with the exception of PKC beta 2, which no longer colocalizes with microtubules in the TPA-resistant cell lines. In contrast to wt-U937 cells, the resistant cells do not express beta 2-integrin adhesion molecules, cd11b and cd11c, on the cell surface following TPA treatment but do express cd11b and cd11c in intracellular vesicles. TPA stimulates the translocation of these vesicles to the cell surface in wt U937 cells but not in the resistant cells. These results suggest that events downstream of PKC activation may mediate cytoskeletal reorganization and beta 2-integrin transport to the cell surface in wt-U937 cells but not in the differentiation-resistant cells.
This article has been cited by other articles:
![]() |
S. Plenchette, S. Cathelin, C. Rebe, S. Launay, S. Ladoire, O. Sordet, T. Ponnelle, N. Debili, T.-H. Phan, R.-A. Padua, et al. Translocation of the inhibitor of apoptosis protein c-IAP1 from the nucleus to the Golgi in hematopoietic cells undergoing differentiation: a nuclear export signal-mediated event Blood, October 1, 2004; 104(7): 2035 - 2043. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. H. Whelan, S. C. Kiley, and P. J. Parker Tetradecanoyl Phorbol Acetate-induced Microtubule Reorganization Is Required for Sustained Mitogen-activated Protein Kinase Activation and Morphological Differentiation of U937 Cells Cell Growth Differ., April 1, 1999; 10(4): 271 - 277. [Abstract] [Full Text] |
||||
![]() |
T. Ng, A. Squire, G. Hansra, F. Bornancin, C. Prevostel, A. Hanby, W. Harris, D. Barnes, S. Schmidt, H. Mellor, et al. Imaging Protein Kinase C Activation in Cells Science, March 26, 1999; 283(5410): 2085 - 2089. [Abstract] [Full Text] |
||||
![]() |
M. Kaneki, S. Kharbanda, P. Pandey, K. Yoshida, M. Takekawa, J.-R. Liou, R. Stone, and D. Kufe Functional Role for Protein Kinase Cbeta as a Regulator of Stress-Activated Protein Kinase Activation and Monocytic Differentiation of Myeloid Leukemia Cells Mol. Cell. Biol., January 1, 1999; 19(1): 461 - 470. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Prekeris, R. M. Hernandez, M. W. Mayhew, M. K. White, and D. M. Terrian Molecular Analysis of the Interactions between Protein Kinase C-epsilon and Filamentous Actin J. Biol. Chem., October 9, 1998; 273(41): 26790 - 26798. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Schönwasser, R. M. Marais, C. J. Marshall, and P. J. Parker Activation of the Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Pathway by Conventional, Novel, and Atypical Protein Kinase C Isotypes Mol. Cell. Biol., February 1, 1998; 18(2): 790 - 798. [Abstract] [Full Text] |
||||
![]() |
R. Datta, K. Yoshinaga, M. Kaneki, P. Pandey, and D. Kufe Phorbol Ester-induced Generation of Reactive Oxygen Species Is Protein Kinase Cbeta -dependent and Required for SAPK Activation J. Biol. Chem., December 22, 2000; 275(52): 41000 - 41003. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |